We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+7.66%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$455B
AUM Growth
+$26.6B
Cap. Flow
-$26.7B
Cap. Flow %
-5.87%
Top 10 Hldgs %
33.25%
Holding
16,292
New
1,466
Increased
6,223
Reduced
6,687
Closed
1,652

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$645M
2
TMUS icon
T-Mobile US
TMUS
+$640M
3
T icon
AT&T
T
+$517M
4
HUM icon
Humana
HUM
+$481M
5
BSX icon
Boston Scientific
BSX
+$400M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.24B
2
AAPL icon
Apple
AAPL
+$755M
3
META icon
Meta Platforms (Facebook)
META
+$707M
4
CAT icon
Caterpillar
CAT
+$472M
5
AMD icon
Advanced Micro Devices
AMD
+$449M

Sector Composition

Rank Sector Weight
1 Healthcare 3.33%
2 Technology 3.2%
3 Financials 2.22%
4 Industrials 2.17%
5 Consumer Discretionary 2.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALGS icon
13401
CALL
Aligos Therapeutics
ALGS
$43M
$11K ﹤0.01%
504
+220
+77% +$8.41K
STKH
13402
Steakholder Foods
STKH
$2.13M
$11K ﹤0.01%
+13
New +$14K
TG icon
13403
PUT
Tredegar Corp
TG
$276M
$11K ﹤0.01%
+1,200
New +$13.3K
IVT icon
13404
InvenTrust Properties
IVT
$2.62B
$11K ﹤0.01%
468
-77,814
-99% -$1.84M
RGLS
13405
CALL
DELISTED
Regulus Therapeutics
RGLS
$10.9K ﹤0.01%
12,920
-7,200
-36% -$9.52K
GSBD icon
13406
PUT
Goldman Sachs BDC
GSBD
$1.11B
$10.9K ﹤0.01%
800
-4,700
-85% -$70.2K
CELL
13407
PUT
DELISTED
PhenomeX Inc. Common Stock
CELL
$10.9K ﹤0.01%
9,400
+2,900
+45% +$5.3K
BEST
13408
CALL
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
$10.9K ﹤0.01%
3,450
+1,980
+135% +$5.83K
ADAP
13409
CALL
DELISTED
Adaptimmune Therapeutics
ADAP
$10.9K ﹤0.01%
10,000
-1,100
-10% -$1.7K
MNDO icon
13410
CALL
Mind CTI
MNDO
$20.6M
$10.9K ﹤0.01%
5,500
+4,800
+686% +$10.8K
HRTX icon
13411
PUT
Heron Therapeutics
HRTX
$63.9M
$10.9K ﹤0.01%
7,200
-3,800
-35% -$9.52K
FPH icon
13412
CALL
Five Point Holdings
FPH
$371M
$10.9K ﹤0.01%
4,600
+4,500
+4,500% +$10.5K
HI
13413
DELISTED
Hillenbrand
HI
$10.8K ﹤0.01%
228
-105,236
-100% -$4.83M
STXS icon
13414
PUT
Stereotaxis
STXS
$138M
$10.8K ﹤0.01%
5,300
+4,100
+342% +$9.22K
GTY
13415
PUT
Getty Realty Corp
GTY
$2.05B
$10.8K ﹤0.01%
300
-2,200
-88% -$77.1K
PXE icon
13416
PUT
Invesco Energy Exploration & Production ETF
PXE
$86.4M
$10.8K ﹤0.01%
400
-400
-50% -$11.4K
AVXL icon
13417
Anavex Life Sciences
AVXL
$298M
$10.8K ﹤0.01%
1,258
-191,781
-99% -$1.91M
ALPP
13418
CALL
DELISTED
Alpine 4 Holdings Inc
ALPP
$10.8K ﹤0.01%
2,638
+950
+56% +$4.37K
FXH icon
13419
PUT
First Trust Health Care AlphaDEX Fund
FXH
$1.11B
$10.8K ﹤0.01%
100
DCFC
13420
PUT
DELISTED
Tritium DCFC Limited Ordinary Shares
DCFC
$10.8K ﹤0.01%
42
-93
-69% -$27.2K
NGL icon
13421
CALL
NGL Energy Partners
NGL
$2.24B
$10.7K ﹤0.01%
3,700
-92,500
-96% -$218K
MFG icon
13422
CALL
Mizuho Financial
MFG
$132B
$10.7K ﹤0.01%
3,800
-7,800
-67% -$23.9K
TEF
13423
CALL
DELISTED
Telefonica
TEF
$10.7K ﹤0.01%
2,500
-7,900
-76% -$31.3K
EWTX icon
13424
CALL
Edgewise Therapeutics
EWTX
$4.8B
$10.7K ﹤0.01%
1,600
-1,200
-43% -$11.1K
CSLMW
13425
DELISTED
CSLM Acquisition Corp. Warrant
CSLMW
$10.7K ﹤0.01%
286,633
-156,667
-35% -$5.76K

Similar funds

Ken Griffin's Q1 2023 Portfolio in Review

As of Q1 2023, Ken Griffin held 16,292 positions worth $455B, up 6.2% from $428B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Ken Griffin withdrew a net $26.7B in Q1 2023, closing 1,652 positions and reducing 6,687 holdings. Its most notable exit was Restaurant Brands International, an estimated $93.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 3.3% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.

Against the trend, Ken Griffin opened a new position in Keurig Dr Pepper worth $238M.

  • Ken Griffin's largest Q1 2023 buy was Keurig Dr Pepper: 6,751,572 shares worth $238M.
  • Ken Griffin added most to Invesco QQQ Trust in Q1 2023, an estimated $645M increase.
  • Ken Griffin's biggest Q1 2023 reduction was Tesla, cutting an estimated $1.24B.
  • Ken Griffin fully exited Restaurant Brands International in Q1 2023, selling an estimated $93.3M.
  • Ken Griffin's ten largest holdings make up 33% of its $455B portfolio in Q1 2023.
  • Ken Griffin opened 1,466 new positions and closed 1,652 in Q1 2023.
  • Ken Griffin's portfolio value rose 6.2% quarter-over-quarter to $455B.

Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.